Khaled Musallam/LinkedIn
Sep 8, 2026, 08:23
Khaled Musallam: A Masterclass on Thalassemia Care in the MENA Region
Khaled Musallam, Group Chief Research Officer at Burjeel Holdings, shared a post on LinkedIn:
“Looking forward to this virtual 2-day Masterclass: ‘The MENA Thalassemia Experience’ on 30-31 October 2026.
This masterclass is developed and organized in collaboration with the Thalassaemia International Federation (TIF) and Medscape Education Global.
The immersive 2-day masterclass is designed for both experienced physicians and physicians in training across the Middle East and North Africa (MENA) region.
Limited ‘seats’ available, apply now to secure your place!”
Find more posts featuring Khaled Musallam on Hemostasis Today.
-
Sep 8, 2026, 09:03Michel Cabrera Ortega: LAAC vs OAC – Which Risk Are We Trading?
-
Sep 8, 2026, 08:58Zehraan Ibni Akbar: Peripheral Blood Smear – A Window into Hematological Diagnosis
-
Sep 8, 2026, 08:50Dirk Sibbing: Potent P2Y12 Inhibition in Patients With Atrial Fibrillation and Acute Coronary Syndrome
-
Sep 8, 2026, 08:39ASH-a-Palooza – Exploring What’s Next in Hematology
-
Sep 8, 2026, 08:23Atoosa Salimi: The Role of Platelet-Derived Serotonin in Severe COVID-19
-
Sep 8, 2026, 07:59Mohammedsefa Arusi Dari: Iron-Deficiency Anemia and Obstructive Sleep Apnea – What Does the Evidence Show?
-
Sep 8, 2026, 07:50Isabelle Ducellier: Exploring the Science Behind Improved Iron Uptake
-
Sep 8, 2026, 07:32Abdulelah Alhazmi: Ischemic Stroke After LV Thrombus Resolution
-
Sep 8, 2026, 07:24Damilola Olowe: Heavy Periods Aren’t Something to ‘Push Through’